De novo mutation of keratin 9 gene in two Taiwanese patients with epidemiolytic palmoplantar keratoderma

Journal of the Formosan Medical Association

Volumn 102, Issue 7, 2003, Pages 492-496

  Yang, Mei Hui ^a   Lee, Julia Yu Yun ^b   Lin, Jeng Hsien ^b   Chao, Sheau Chiou ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Keratin 9, DNA mutational analysis; Keratoderma, palmopantar; Taiwan

Indexed keywords

ARGININE; CYTOSINE; GLUTAMINE; KERATIN; NUCLEOTIDE; THYMINE; TRYPTOPHAN;

ADULT; ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CELL DEGENERATION; CODON; CYTOLYSIS; ELECTRON MICROSCOPY; EPIDERMOLYSIS; ETHNOLOGY; GENE IDENTIFICATION; GENE MUTATION; GENE STRUCTURE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINIZATION; KERATINOCYTE; KERATOSIS PALMOPLANTARIS; MALE; NUCLEIC ACID BASE SUBSTITUTION; PARENT; PEDIGREE; PROTEIN ASSEMBLY; PROTEIN DOMAIN; SCHOOL CHILD; TAIWAN;

ADULT; CHILD; DNA MUTATIONAL ANALYSIS; HUMANS; KERATINS; KERATODERMA, PALMOPLANTAR; MALE; MUTATION; POLYMERASE CHAIN REACTION; TAIWAN;

EID: 0346270257     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vörner H: Zur Kenntnis des Keratoma hereditarium palmare et plantare. Arch Dermatol Syph 1901;56:3-31.
2. Navsaria HA, Swensson O, Ratnavel RC, et al: Ultrastructural changes resulting from keratin-9 gene mutations in two families with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995;104:425-9.
3. Steinert PM: The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J Biol Chem 1990;265:8766-74.
4. Irvine AD, McLean WH: Human keratin diseases: the increasing spetrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999;140:815-28.
5. Lane EB: Keratins. In: Royce PM, Steinmenn B, editors. Connective tissue and its heritable disorders. Molecular, genetic and medical aspect. New York: Wiley-Liss Inc,; 1993:237-47.
6. Knapp AC, Franke WW, Heid H, et al: Cytokeratin No. 9, an epidermal type I keratin characteristic of a special program of keratinocyte differentation displaying body site specificity. J Cell Biol 1986;103:657-67.
7. Reis A, Kuster Eckardt R, et al: Mapping of a gene for epidermolytic palmoplantar keratiderma to the region of the acidic keratin gene cluster at 17q12-q21. Hum Genet 1992;90:113-6.
8. Reis A, Hennies HC, Langbein, et al: Keratib 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 1994;6:174-9.
9. Torchard D, Blanchet-Bardon C, Serova O, et al: Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat Genet 1994;6:106-10.
10. Hennies HC, Zehender D, Kunze J, et al: Keratin 9 gene mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma. Hum Genet 1994;93:649-54.
11. Bonifas JM, Matsumura K, Chen MA, et al: Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis. J Invest Dermatol 1994;103:474-7.
12. Rothnagel JA, Wojcik S, Liefer KM, et al: Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995;104:430-3.
13. Covello SP, Irvine AD, McKenna KE, et al: Mutations in keratin K9 in kindreds with epidermolytic palmoplantar keratoderma and epidemiology in Northern Ireland. J Invest Dermatol 1998; 111:1207-9.
14. Szalai S, Szalai C, Becker K, et al: Keratin 9 mutations in the coil 1A region in epidermolytic palmoplantar keratoderma. Pediatr Dermatol 1999; 16:430-5.
15. Endo H, Hatamochi A, Shinkai H. A novel mutation of a leucine residue in coil 1A of keratin 9 in epidermolytic palmoplantar keratoderma. J Invest Dermatol 1997;109:113-5.
16. Mayuzumi N, Shigihara T, Ikeda S, et al: R162W mutation of keratin 9 in a family with autosomal dominant palmoplantar keratoderma with unique histologic features. J Invest Dermatol 1999;4:150-2.
17. Yang JM, Lee S, Kang HJ, et al: Mutations in the 1A rod domain segment of the keratin 9 in patients with epidermolytic palmoplantar keratoderma. Acta Derm Venereol 1998;78:412-6.
18. Steinert PM, Marekov LN, Parry DA: Diversity of intermediate filament structure. Evidence that the alignment of coiled-coil molecules in vimentin is different from that in keratin intermediate filaments. J Biol Chem 1993;268:24916-25.
19. Coleman CM, Munro CS, Smith FJ, et al: Epidermolytic palmoplantar keratoderma due to a novel type of keratin mutation, a 3-bp insertion in the keratin 9 helix termination motif. Br J Dermatol 1999;140:486-90.
20. Morgan VA, Byron K, Paiman L, Varigos GA. A case of spontaneous mutation in the keratin 9 gene associated with epidermolytic palmoplantar keratoderma. Australas J Dermatol 1999;40:215-6.
21. Coulombe PA, Hutton ME, Letai A, et al: Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 1991;66:1301-11.
22. Rothnagel JA, Fisher MP, Axtell SM, et al: A mutational hot spot in keratin 10 (KRT 10) in patients with epidermolytic hyperkeratosis. Hum Mol Genet 1993;2:2147-50.
23. Shamsher MK, Navsaria HA, Stevens HP, et al: Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet 1995;4:1875-81.
24. Smith FJ, Corden LD, Rugg EL, et al: Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997; 108:220-3.
25. Cooper DN, Youssoufian H: The CpG dinucleotide and human genetic disease. Hum Genet 1988;78:151-5.
26. Bergfeld WF, Derbes VJ, Elias PM, et al: The treatment of keratosis palmaris et plantaris with isotretinoin. A multicenter study. J Am Acad Dermatol 1982;6(4 pt2 Suppl):727-31.